- Home
- ANVS vs DRIO Comparison
ANVS vs DRIO Comparison
Compare ANVS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- DRIO
- Stock Information
- Founded
- ANVS 2008
- DRIO 2011
- Country
- ANVS United States
- DRIO United States
- Employees
- ANVS N/A
- DRIO N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- ANVS Health Care
- DRIO Health Care
- Exchange
- ANVS Nasdaq
- DRIO Nasdaq
- Market Cap
- ANVS 24.2M
- DRIO 28.3M
- IPO Year
- ANVS 2020
- DRIO N/A
- Fundamental
- Price
- ANVS $2.35
- DRIO $0.72
- Analyst Decision
- ANVS Strong Buy
- DRIO Strong Buy
- Analyst Count
- ANVS 5
- DRIO 2
- Target Price
- ANVS $34.75
- DRIO $2.50
- AVG Volume (30 Days)
- ANVS 434.1K
- DRIO 157.7K
- Earning Date
- ANVS 05-13-2025
- DRIO 05-14-2025
- Dividend Yield
- ANVS N/A
- DRIO N/A
- EPS Growth
- ANVS N/A
- DRIO N/A
- EPS
- ANVS N/A
- DRIO N/A
- Revenue
- ANVS N/A
- DRIO $28,034,000.00
- Revenue This Year
- ANVS N/A
- DRIO $16.54
- Revenue Next Year
- ANVS N/A
- DRIO $21.93
- P/E Ratio
- ANVS N/A
- DRIO N/A
- Revenue Growth
- ANVS N/A
- DRIO 47.20
- 52 Week Low
- ANVS $1.11
- DRIO $0.50
- 52 Week High
- ANVS $17.88
- DRIO $1.57
- Technical
- Relative Strength Index (RSI)
- ANVS 68.59
- DRIO 52.54
- Support Level
- ANVS $1.95
- DRIO $0.63
- Resistance Level
- ANVS $2.58
- DRIO $0.74
- Average True Range (ATR)
- ANVS 0.22
- DRIO 0.05
- MACD
- ANVS 0.06
- DRIO 0.00
- Stochastic Oscillator
- ANVS 79.09
- DRIO 56.73
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.